Alembic Pharma up 3%, anti-inflammatory drug gets USFDA nod

Alembic Pharma up 3%, anti-inflammatory drug gets USFDA nod

Shares of Alembic Pharmaceuticals climbed 2.8 percent in early trade Friday on getting tentative approval from US Food and Drug Administration (USFDA) for its anti-inflammatory drug. The pharma company today has received tentative approval from USFDA …

(Visited 4 times, 1 visits today)
9
Like
Save

Comments

Comments are disabled for this post.